Indiana Palliative Excellence in Alzheimer Care Efforts-RCT
Indiana Palliative Excellence in Alzheimer Care Efforts-RCT
批准号:
9924430
负责人:
GREG A SACHS
金额:
$69.28万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-08-01 至 2023-04-30
关键词:
AddressAdultAdvance Care PlanningAdverse effectsAffectAge-YearsAggressive behaviorAgitationAlzheimer&aposs DiseaseAlzheimer&aposs disease careAlzheimer&aposs disease related dementiaAmericanAnxietyBlindedCaregiver BurdenCaregiver supportCaregiversCaringCause of DeathClinicalCollaborationsCommunitiesCommunity ServicesComprehensive Health CareControl GroupsDementiaDementia caregiversDepressed moodDistressEmergency department visitEnrollmentEnsureEquipment and supply inventoriesEvidence based interventionFamilyFamily CaregiverFamily memberFutureGoalsHealthHealth systemHome environmentHospitalizationHospitalsIndianaInterdisciplinary StudyInterventionInterviewModelingMoodsNatureNetwork-basedNursing HomesOutcomeOutcome AssessmentPainPain managementPalliative CarePatient CarePatientsPersonsPharmaceutical PreparationsPopulationPrevalenceProtocols documentationProviderPublic HealthRandomizedRandomized Controlled TrialsReactionResearchResearch AssistantRiskShapesShoulderSocial WorkersSocietiesStressSupportive careSymptomsTelephoneTestingTimeUnited StatesWorkbasecare providerscare systemscommunity settingdementia careempoweredend of lifeevidence baseexperiencefamily supportfeedinghospice environmentimprovedinnovationintervention effectmeetingsmulti-component interventionmultidisciplinaryneuropsychiatric symptomneuropsychiatrypalliativepersonalized carepreferencerecruitrepetitive behaviorsymptom managementtreatment as usualtreatment grouptreatment planningtrial comparingusual care arm
中文摘要
项目总结/摘要
痴呆症是一种普遍的、日益严重的公共卫生问题;超过500万美国人患有这种疾病,
预计到2050年将有多达1 600万人受到影响。痴呆症的神经精神症状通常
用药物治疗,其副作用的证据大于益处。痴呆症患者
存在对疼痛认识和管理不足的风险;接受繁重的治疗;并患有
姑息治疗服务参与不足。面对家庭护理人员得不到足够的支持
巨大的压力。患者和家庭没有得到痴呆症的干预和模型的良好服务-
具体护理和姑息治疗是相互排斥的选择。这项研究的总体目标是由博士。
萨克斯的团队是为了改善社区居住的痴呆症患者及其家庭照顾者的护理
通过创新的支持性护理模式,结合现有的,基于证据的干预措施,
老年痴呆症护理与创新的干预措施,为姑息治疗老年痴呆症。干预计划体现了这种护理
进入患者和护理人员的家中,赋予护理人员权力,并与持续护理相结合。的
一项拟定的随机对照试验比较了IN-PEACE干预(印第安纳州版本的姑息治疗)和
卓越的阿尔茨海默氏症护理工作),以常规护理社区居住的患者,中度至重度
老年痴呆症及其家庭护理人员。IN-PEACE将入组200名患者-护理人员配对,随机分配100名
干预组和常规护理组各成对,随访24个月,结局评估为3,
6、9、12、15、18、21和24个月,研究助理对治疗组设盲。核心的多-
成分干预是由痴呆症护理协调员(DCC;社会
工作人员或RN)预测和识别患者的症状和护理人员的需求,并利用
具体的循证治疗方案协议涵盖基本的痴呆症护理,照顾者的痛苦,神经精神
症状,疼痛,在医院导航,喂养困难,过渡到临终关怀。干预还
涉及提前护理规划和支持,照顾者根据痴呆症护理中面临的决定量身定制,
强调姑息治疗方案可以取代通常导致繁重治疗的默认方案。
DCC由跨学科研究团队的每周会议提供支持,并与
患者的初级保健提供者和社区服务。IN-PEACE的主要目的是测试
对患者神经精神症状的干预。其他目标包括测试国际和平组织对
患者的整体症状结果,照顾者的情绪和痛苦,以及负担的提供
患者的治疗(住院和急诊室就诊)。国际和平组织基于一种创新的
支持性护理模式;采用创新的干预措施,整合了基于证据的痴呆症护理,
姑息治疗;并被派往一个创新的实践为基础的网络,重点是加强痴呆症护理
在社区这将是此类研究中的第一次,重塑这一领域未来干预措施的性质。
英文摘要
PROJECT SUMMARY/ABSTRACT
Dementia is a prevalent, growing public health problem; over 5 million Americans suffer from the condition and
up to 16 million people are projected to be affected by 2050. Neuropsychiatric symptoms in dementia are often
treated with medications having greater evidence of adverse effects than benefits. Patients with dementia are
at risk for inadequate recognition and management of pain; receive burdensome treatments; and suffer with
insufficient involvement of palliative care services. Family caregivers receive inadequate support in the face of
substantial stress. Patients and families are poorly served by interventions and models that present dementia-
specific care and palliative care as mutually exclusive options. The overarching goal of this research by Dr.
Sachs’s team is to improve the care of community dwelling patients with dementia and their family caregivers
through an innovative model of supportive care that combines an existing, evidence-based intervention for
dementia care with an innovative intervention for palliative care in dementia. The intervention projects this care
into the homes of patients and caregivers, empowering caregivers, and integrating with ongoing care. The
proposed randomized controlled trial compares the IN-PEACE intervention (Indiana version of Palliative
Excellence in Alzheimer Care Efforts) to usual care for community dwelling patients with moderate to severe
dementia and their family caregivers. IN-PEACE will enroll 200 patient-caregiver dyads, randomizing 100
dyads each to the intervention and usual care arms and follow for 24 months with outcome assessments at 3,
6, 9, 12, 15, 18, 21 and 24 months by research assistants blinded to treatment group. The core of the multi-
component intervention is regular, proactive telephone contact by a dementia care coordinator (DCC; social
worker or RN) to anticipate and identify patients’ symptoms and caregivers needs and address them utilizing
specific, evidence-based protocols. Protocols cover basic dementia care, caregiver distress, neuropsychiatric
symptoms, pain, navigating the hospital, feeding difficulties, and transition to hospice. The intervention also
involves advance care planning and support with caregivers tailored to decisions faced in dementia care,
highlighting where palliative care options can replace the default that often results in burdensome treatments.
DCCs are supported by weekly meetings of the interdisciplinary research team, as well as collaboration with
patients’ primary care providers and community services. The primary aim of IN-PEACE is to test the effect of
the intervention on patients’ neuropsychiatric symptoms. Other aims include testing the effect of IN-PEACE on
patients’ overall symptom outcomes, caregiver mood and distress, and the provision of burdensome
treatments to patients (hospitalizations and emergency room visits). IN-PEACE is based on an innovative
supportive care model; utilizes an innovative intervention that integrates evidence-based dementia care and
palliative care; and is fielded in an innovative practice based network that focuses on enhancing dementia care
in the community. This will be the first study of its kind, reshaping the nature of future interventions in this field.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Ethics of Medication Deprescribing in Dementia Care
-
批准号:9929264
-
项目类别:
-
资助金额:$11.3万
-
财政年份:2018
-
负责人:GREG A SACHS
-
依托单位:
Indiana Palliative Excellence in Alzheimer Care Efforts-RCT
-
批准号:10394808
-
项目类别:
-
资助金额:$68.05万
-
财政年份:2018
-
负责人:GREG A SACHS
-
依托单位:
Optimal Prevention & Treatment In Medically Complex Alzheimer Patients (OPTIMAL)
-
批准号:7534918
-
项目类别:
-
资助金额:$13.36万
-
财政年份:2008
-
负责人:GREG A SACHS
-
依托单位:
Optimal Prevention & Treatment In Medically Complex Alzheimer Patients (OPTIMAL)
-
批准号:7666801
-
项目类别:
-
资助金额:$13.36万
-
财政年份:2008
-
负责人:GREG A SACHS
-
依托单位:
How Exam Rooms Enhance Physicians' Patient-Centeredness
-
批准号:6831390
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2004
-
负责人:GREG A SACHS
-
依托单位:
DEMENTIA RESEARCH: INFORMED, PROXY, AND ADVANCE CONSENT
-
批准号:2545183
-
项目类别:
-
资助金额:$27.95万
-
财政年份:1997
-
负责人:GREG A SACHS
-
依托单位:
DEMENTIA RESEARCH: INFORMED, PROXY, AND ADVANCE CONSENT
-
批准号:2904301
-
项目类别:
-
资助金额:$25.3万
-
财政年份:1997
-
负责人:GREG A SACHS
-
依托单位:
DEMENTIA RESEARCH: INFORMED, PROXY, AND ADVANCE CONSENT
-
批准号:6335281
-
项目类别:
-
资助金额:$5.3万
-
财政年份:1997
-
负责人:GREG A SACHS
-
依托单位:
DEMENTIA RESEARCH: INFORMED, PROXY, AND ADVANCE CONSENT
-
批准号:2769442
-
项目类别:
-
资助金额:$25.3万
-
财政年份:1997
-
负责人:GREG A SACHS
-
依托单位:
GERIATRIC ACADEMIC PROGRAM AWARD
-
批准号:2769260
-
项目类别:
-
资助金额:$50.65万
-
财政年份:1991
-
负责人:GREG A SACHS
-
依托单位:
GERIATRIC ACADEMIC PROGRAM AWARD
-
批准号:6168618
-
项目类别:
-
资助金额:$44.01万
-
财政年份:1991
-
负责人:GREG A SACHS
-
依托单位:
GERIATRIC ACADEMIC PROGRAM AWARD
-
批准号:6055322
-
项目类别:
-
资助金额:$50.65万
-
财政年份:1991
-
负责人:GREG A SACHS
-
依托单位:
海外基金